National Drug Control Budget - FY 2017 Funding Highlights - Office of National Drug Control Policy - Libros - Createspace Independent Publishing Platf - 9781530341047 - 3 de marzo de 2016
En caso de que portada y título no coincidan, el título será el correcto

National Drug Control Budget - FY 2017 Funding Highlights

Precio
Mex$ 341
sin IVA

Pedido desde almacén remoto

Entrega prevista 2 - 18 de sep.
Recibe notificaciones sobre nuevos lanzamientos de Office of National Drug Control Policy
Añadir a tu lista de deseos de iMusic

Aún no valorado

In FY 2017, a total of $31.1 billion is requested by the President to support National Drug Control Strategy (Strategy) efforts to reduce drug use and its consequences in the United States. This represents an increase of more than $500 million (1.7 percent) over the enacted FY 2016 level of $30.6 billion. The Administration's 21st century approach to drug policy works to reduce illicit drug use and its consequences in the United States. This evidence-based plan, which balances public health and public safety efforts to prevent, treat, and provide recovery from the disease of addiction, seeks to build a healthier, safer, and more prosperous country. The FY 2017 drug control funding request recognizes the significant progress made in addressing challenges along the spectrum of drug policy with the significant drug-related challenges that continue to threaten public health and safety. In FY 2017, for the first time, the Administration proposes more funding for demand reduction efforts than those focused on supply reduction. The National Drug Control Budget: FY 2017 Funding Highlights provides an overview of key funding priorities that support the Strategy and an overview of all drug control funding by function.

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 3 de marzo de 2016
ISBN13 9781530341047
Editores Createspace Independent Publishing Platf
Páginas 24
Dimensiones 216 × 280 × 1 mm   ·   81 g
Lengua Inglés  

Mas por Office of National Drug Control Policy

Mostrar todo